The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: A non-randomized, open-label phase Ib study.
 
Kamran A. Ahmed
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
 
Youngchul Kim
No Relationships to Disclose
 
John Arrington
No Relationships to Disclose
 
Sungjune Kim
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Michelle DeJesus
No Relationships to Disclose
 
Aixa Soyano
No Relationships to Disclose
 
Avan J. Armaghani
No Relationships to Disclose
 
Ricardo L Costa
Honoraria - Bristol-Myers Squibb (I)
 
Hung T. Khong
Stock and Other Ownership Interests - Aptose Biosciences; Array BioPharma; Aveo; Avinger; Cellectar; Exelixis; Immunomedics; Kadmon; Lipocine; MEI Pharma; Molecular Templates; MustangBio; TG Therapeutics; Tiziana Life Sciences; Vaxart
Consulting or Advisory Role - Lilly; Novartis; Puma Biotechnology
Research Funding - AstraZeneca; Lilly; Radius Health
 
Marilin Rosa
No Relationships to Disclose
 
Jimmy J. Caudell
Honoraria - Varian Medical Systems
Consulting or Advisory Role - Varian Medical Systems
Research Funding - Varian Medical Systems
 
Roberto Diaz
No Relationships to Disclose
 
Timothy J. Robinson
No Relationships to Disclose
 
Arnold B. Etame
No Relationships to Disclose
 
Nam D. Tran
No Relationships to Disclose
 
Solmaz Sahebjam
Stock and Other Ownership Interests - Abbvie; Allergan
Consulting or Advisory Role - Boehringer Ingelheim; Merck
Research Funding - Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Immunomedics; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Sanofi
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; BTG; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Department of Defense; Florida Academic Cancer Center Alliance; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCI; NIH; Physical Sciences Oncology Network
 
Hsiang-Hsuan Michael Yu
Honoraria - Brainlab
Consulting or Advisory Role - Abbvie; Novocure
 
Hyo S. Han
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)